|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Zhang X, Chen L, Zhao Q and Xia X:
Cancer incidence and mortality in Gansu province, 2012. Chin J
Cancer Res. 28:301–310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zeng H, Zuo T,
Jia M, Xia C, Zou X and He J: Report of cancer incidence and
mortality in China, 2012. China Cancer. 25:1–8. 2016.
|
|
4
|
Guo Q, Liu X, Lu L, Yuan H, Wang Y, Chen
Z, Ji R and Zhou Y: Comprehensive evaluation of clinical efficacy
and safety of celecoxib combined with chemotherapy in management of
gastric cancer. Medicine (Baltimore). 96:e88572017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji R: Gastric cancer screening and related
risk factors analysis in the Wuwei Natrual population cohort.
Lanzhou University; 2018
|
|
6
|
Pasechnikov V, Chukov S, Fedorov E,
Kikuste I and Leja M: Gastric cancer: Prevention, screening and
early diagnosis. World J Gastroenterol. 20:13842–13862. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Everett SM and Axon AT: Early gastric
cancer in Europe. Gut. 41:142–150. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki H, Oda I, Abe S, Sekiguchi M, Mori
G, Nonaka S, Yoshinaga S and Saito Y: High rate of 5-year survival
among patients with early gastric cancer undergoing curative
endoscopic submucosal dissection. Gastric Cancer. 19:198–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gong W, Luo S, Hu R, Wang H, Pan J, Fei F,
Wu H and Yu M: Survival analysis of gastric cancer patients during
2005–2010 in Zhejiang Province, China. Zhonghua Zhong Liu Za Zhi.
36:636–639. 2014.(In Chinese). PubMed/NCBI
|
|
11
|
Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen
S, Li X, Gu J and Zheng Y: The survival and the long-term trends of
patients with gastric cancer in Shanghai, China. BMC Cancer.
14:3002014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamashima C, Shabana M, Okada K, Okamoto M
and Osaki Y: Mortality reduction from gastric cancer by endoscopic
and radiographic screening. Cancer Sci. 106:1744–1749. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
So JBY, Kapoor R, Zhu F, Koh C, Zhou L,
Zou R, Tang YC, Goo PCK, Rha SY, Chung HC, et al: Development and
validation of a serum microRNA biomarker panel for detecting
gastric cancer in a high-risk population. Gut. 70:829–837. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han J, Lee Y, Yeom KH, Kim YK, Jin H and
Kim VN: The Drosha-DGCR8 complex in primary microRNA processing.
Genes Dev. 18:3016–3027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng GD, Xu ZY, Hu C, Lv H, Xie XH, Huang
T, Zhang YQ, Chen GP, Fu YF and Cheng XD: Exosomal miR-590-5p in
serum as a biomarker for the diagnosis and prognosis of gastric
cancer front. Mol Biosci. 8:6365662021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang
J, Yang X and Liu Z: Exosomal miR-1246 in serum as a potential
biomarker for early diagnosis of gastric cancer. Int J Clin Oncol.
25:89–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin VY and Chu KM: MiRNA as potential
biomarkers and therapeutic targets for gastric cancer. World J
Gastroenterol. 20:10432–10439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu M, Hu C, Wu F, Shu L, Pan Y, Liu X, Liu
P, Ma F, Deng C and Huang M: MiR-320a is associated with cisplatin
resistance in lung adenocarcinoma and its clinical value in
non-small cell lung cancer: A comprehensive analysis based on
microarray data. Lung Cancer. 147:193–197. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amin MB, Edge SB, Greene FI, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC cancer staging manual. Springer-Verlag New
York, the United States: 2016
|
|
23
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Han X, Wan Y, Zhang S, Zhao Y, Fan
R, Cui Q and Zhou Y: TAM 2.0: Tool for MicroRNA set analysis.
Nucleic Acids Res. 46:W180–W185. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gaudet P and Dessimoz C: Gene ontology:
Pitfalls, biases, and remedies. Methods Mol Biol. 1446:189–205.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wickham H: ggplot2: Elegant Graphics for
Data Analysis. Springer-Verlag; New York, NY: 2016
|
|
32
|
Chen Y and Wang X: miRDB: An online
database for prediction of functional microRNA targets. Nucleic
Acids Res. 48:D127–D131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Therneau TM and Grambsch PM: Modeling
Survival Data: Extending the Cox Model. Springer-Verlag; New York,
NY: 2000, View Article : Google Scholar
|
|
37
|
Brusselaers N, Maret-Ouda J, Konings P,
El-Serag HB and Lagergren J: Menopausal hormone therapy and the
risk of esophageal and gastric cancer. Int J Cancer. 140:1693–1699.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu M, Zhu J, Ling Y, Shi W, Zhang C and Wu
H: The lower expression of gonadotropin-releasing hormone receptor
associated with poor prognosis in gastric cancer. Int J Clin Exp
Med. 8:13365–13370. 2015.PubMed/NCBI
|
|
39
|
Yang S, Liu W, Wen J, Zhu M and Xu S:
Corticotropin releasing hormone is correlated with tumorigenesis of
gastric cancer. Cancer Invest. 31:167–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Frycz BA, Murawa D, Borejsza-Wysocki M,
Wichtowski M, Spychała A, Marciniak R, Murawa P, Drews M and
Jagodziński PP: mRNA expression of steroidogenic enzymes, steroid
hormone receptors and their coregulators in gastric cancer. Oncol
Lett. 13:3369–3378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gan J, Ke X, Jiang J, Dong H, Yao Z, Lin
Y, Lin W, Wu X, Yan S, Zhuang Y, et al: Growth hormone-releasing
hormone receptor antagonists inhibit human gastric cancer through
downregulation of PAK1-STAT3/NF-κB signaling. Proc Natl Acad Sci
USA. 113:14745–14750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yamada T, Yoshikawa T, Taguri M, Hayashi
T, Aoyama T, Sue-Ling HM, Bonam K, Hayden JD and Grabsch HI: The
survival difference between gastric cancer patients from the UK and
Japan remains after weighted propensity score analysis considering
all background factors. Gastric Cancer. 19:479–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kerckhoffs KGP, Liu DHW, Saragoni L, van
der Post RS, Langer R, Bencivenga M, Iglesias M, Gallo G, Hewitt
LC, Fazzi GE, et al: Mucin expression in gastric- and
gastro-oesophageal signet-ring cell cancer: Results from a
comprehensive literature review and a large cohort study of
Caucasian and Asian gastric cancer. Gastric Cancer. 23:765–779.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang ZL, Li ZR, Li JS and Wang SR:
Calcium-sensing receptor antagonist NPS-2143 suppresses
proliferation and invasion of gastric cancer cells. Cancer Gene
Ther. 27:548–557. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tang B, Wu J, Zhu MX, Sun X, Liu J, Xie R,
Dong TX, Xiao Y, Carethers JM, Yang S and Dong H: VPAC1 couples
with TRPV4 channel to promote calcium-dependent gastric cancer
progression via a novel autocrine mechanism. Oncogene.
38:3946–3961. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ge C, Li Q, Wang L and Xu X: The role of
axon guidance factor semaphorin 6B in the invasion and metastasis
of gastric cancer. J Int Med Res. 41:284–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pan G, Zhang X, Ren J, Lu J, Li W, Fu H,
Zhang S and Li J: Semaphorin 5A, an axon guidance molecule,
enhances the invasion and metastasis of human gastric cancer
through activation of MMP9. Pathol Oncol Res. 19:11–18. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Park T, Lee YJ, Jeong SH, Choi SK, Jung
EJ, Ju YT, Jeong CY, Park M, Hah YS, Yoo J, et al: Overexpression
of neuron-specific enolase as a prognostic factor in patients with
gastric cancer. J Gastric Cancer. 17:228–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eke I and Cordes N: Focal adhesion
signaling and therapy resistance in cancer. Semin Cancer Biol.
31:65–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Du M, Zheng R, Ma G, Chu H, Lu J, Li S,
Xin J, Tong N, Zhang G, Wang W, et al: Remote modulation of lncRNA
GCLET by risk variant at 16p13 underlying genetic susceptibility to
gastric cancer. Sci Adv. 6:eaay55252020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang F, Chen X, Li X, Chen J, Tang Y, Cai
Y, Wang Y, Chen Z, Li L, Li R and Deng Z: Long intergenic
non-protein coding RNA 1089 suppresses cell proliferation and
metastasis in gastric cancer by regulating
miRNA-27a-3p/epithelial-mesenchymal transition (EMT) axis. Cancer
Manag Res. 12:5587–5596. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Geng G, Liu X, Xu A, Lu Z, Chen K, He J,
Qi D and Yuan X: Low abundance of TFPI-2 by both promoter
methylation and miR-27a-3p regulation is linked with poor clinical
outcome in gastric cancer. J Gene Med. 22:e31662020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou L, Liang X, Zhang L, Yang L, Nagao N,
Wu H, Liu C, Lin S, Cai G and Liu J: MiR-27a-3p functions as an
oncogene in gastric cancer by targeting BTG2. Oncotarget.
7:51943–51954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang J, Liu H, Hou L, Wang G, Zhang R,
Huang Y, Chen X and Zhu J: Circular RNA_LARP4 inhibits cell
proliferation and invasion of gastric cancer by sponging miR-424-5p
and regulating LATS1 expression. Mol Cancer. 16:1512017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei S, Li Q, Li Z, Wang L, Zhang L and Xu
Z: Correction: miR-424-5p promotes proliferation of gastric cancer
by targeting Smad3 through TGF-β signaling pathway. Oncotarget.
8:340182017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wei S, Li Q, Li Z, Wang L, Zhang L and Xu
Z: miR-424-5p promotes proliferation of gastric cancer by targeting
Smad3 through TGF-β signaling pathway. Oncotarget. 7:75185–75196.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liang S, He L, Zhao X, Miao Y, Gu Y, Guo
C, Xue Z, Dou W, Hu F, Wu K, et al: MicroRNA let-7f inhibits tumor
invasion and metastasis by targeting MYH9 in human gastric cancer.
PLoS One. 6:e184092011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Song C, Chen H, Wang T, Zhang W, Ru G and
Lang J: Expression profile analysis of microRNAs in prostate cancer
by next-generation sequencing. Prostate. 75:500–516. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Queiroz AL, Zhang B, Comstock DE, Hao Y,
Eriksson M, Hydbring P, Vakifahmetoglu-Norberg H and Norberg E:
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung
carcinomas. Biochem Biophys Res Commun. 499:314–320. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang C, Zhou B, Liu M, Liu Y and Gao R:
miR-126-5p restoration promotes cell apoptosis in cervical cancer
by targeting Bcl2l2. Oncol Res. 25:463–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mi Y, Zhang D, Jiang W, Weng J, Zhou C,
Huang K, Tang H, Yu Y, Liu X, Cui W, et al: miR-181a-5p promotes
the progression of gastric cancer via RASSF6-mediated MAPK
signalling activation. Cancer Lett. 389:11–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu Z, Sun F, Hong Y, Liu Y, Fen M, Yin K,
Ge X, Wang F, Chen X and Guan W: MEG2 is regulated by miR-181a-5p
and functions as a tumour suppressor gene to suppress the
proliferation and migration of gastric cancer cells. Mol Cancer.
16:1332017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Cui HW, Han WY, Hou LN, Yang L, Li X and
Su XL: miR-1915-3p inhibits Bcl-2 expression in the development of
gastric cancer. Biosci Rep. 39:BSR201823212019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jin ML, Kim YW, Jin HL, Kang H, Lee EK,
Stallcup MR and Jeong KW: Aberrant expression of SETD1A promotes
survival and migration of estrogen receptor α-positive breast
cancer cells. Int J Cancer. 143:2871–2883. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xu K, Liang X, Cui D, Wu Y, Shi W and Liu
J: miR-1915 inhibits Bcl-2 to modulate multidrug resistance by
increasing drug-sensitivity in human colorectal carcinoma cells.
Mol Carcinog. 52:70–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
